TIBI
Code | Size | Price |
---|
TAR-T28973-50mg | 50mg | £644.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28973-100mg | 100mg | £986.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
TIBI is a potent, ATP-competitive inhibitor of CK2 and Rio1.
CAS:
1196457-06-3
Formula:
C7H2I4N2
Molecular Weight:
621.725
Purity:
0.98
SMILES:
Ic1c(I)c(I)c2[nH]cnc2c1I
References
1. Tibi L, van Oppen P, van Balkom AJLM, Eikelenboom M, Rickelt J, Schruers KRJ, Anholt GE. The long-term association of OCD and depression and its moderators: A four-year follow up study in a large clinical sample. Eur Psychiatry. 2017 Apr 7;44:76-82. doi: 10.1016/j.eurpsy.2017.03.009. [Epub ahead of print] PubMed PMID: 28545012.
2. Buckert D, Cieslik M, Tibi R, Radermacher M, Rottbauer W, Bernhardt P. Cardiac magnetic resonance imaging derived quantification of myocardial ischemia and scar improves risk stratification and patient management in stable coronary artery disease. Cardiol J. 2017 Mar 29. doi: 10.5603/CJ.a2017.0036. [Epub ahead of print] PubMed PMID: 28353309.
3. Jurj A, Tomuleasa C, Tat TT, Berindan-Neagoe I, Vesa SV, Ionescu DC. Antiproliferative and Apoptotic Effects of Lidocaine on Human Hepatocarcinoma Cells. A preliminary study. J Gastrointestin Liver Dis. 2017 Mar;26(1):45-50. doi: 10.15403/jgld.2014.1121.261.juj. PubMed PMID: 28338113.
4. Shao Z, Al Tibi M, Wakim-Fleming J. Update on viral hepatitis in pregnancy. Cleve Clin J Med. 2017 Mar;84(3):202-206. doi: 10.3949/ccjm.84a.15139. Review. PubMed PMID: 28322675.